1 |
Details of the person discharging managerial responsibilities / person closely associated |
a) |
Name |
Said Darwazah |
2 |
Reason for the notification |
a) |
Position/status |
Chairman and Chief Executive Officer / PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Extension of a pledge by Darhold Limited from 12,250,000 to 20,450,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Citibank N.A., London Branch. The Chairman and Chief Executive is a director of and shareholder in Darhold Limited with an equity interest of 21.49%. |
c) |
Price(s) and volume(s) |
Price(s): £0.00p Volume(s): 8,200,000 |
d) |
Aggregated information |
Aggregated volume: 8,200,000 Price: £0.00p |
e) |
Date of the transaction |
28 November 2016 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |